What makes OTLK special is how much we can predict.
- Norse 8 very likely to succeed - OTLK will get a meaningful share of the US and EU market. Laws in both regions compel this and legal liability and the need for health care cost control will drive this outcome. - Any reasonable assumption on price per inject ($200 - $500) yields significant revenue. - Any reasonable revenue multiple yields a much higher stock ($40 - $400)
The risk is financing, which can be solved by those holding a significant share of the equity.
Market Data 
Markets 
AI
